Skip to main content
. 2007 Feb 12;64(1):49–56. doi: 10.1111/j.1365-2125.2007.02852.x

Table 3.

Correlation between clozapine dosage (mg day−1 kg−1) and plasma clozapine concentrations (Spearman correlations)

All samples Male (n = 116) Female (n = 77) <40 years (n = 82) ≥40 years old (n = 111) Male smokers (n = 50) Male non-smokers (n = 66)
CLZ (ng ml−1) r = 0.264** 0.352** 0.120 0.365** 0.124 0.371** 0.268*
NCLZ (ng ml−1) r = 0.420** 0.485** 0.310** 0.449** 0.358** 0.505** 0.374**
Sum (ng ml−1) r = 0.322** 0.410** 0.177 0.400** 0.203** 0.418** 0.327**
NCLZ/CLZ r = 0.151* 0.132 0.267** 0.061 0.214* 0.058 0.148
**

Correlation is significant at the 0.01 level (two-tailed).

*

Correlation is significant at the 0.05 level. CLZ, Clozapine; NCLZ, norclozapine.